Gallbladder cancer, a different disease that needs individual trials

被引：14

作者：

Gallardo, J ^{[1
]}

Rubio, B

Villanueva, L

Barajas, O

机构：

[1] Univ Chile, Hosp Clin, Oncol, Santiago, Chile

[2] Univ Chile, Fac Ciencias Quim & Farmaceut, Santiago, Chile

[3] Inst Terapias Oncol Providencia, Santiago, Chile

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 30期

关键词：

D O I：

10.1200/JCO.2005.02.7524

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：7753 / +

页数：2

共 7 条

[1]

*AM CANC SOC, 2004, CANC FACTS FIG, P4

[2]

DOVAL DC, 2001, P AN M AM SOC CLIN, P20

[3]

GALLARDO J, 2002, P AN M AM SOC CLIN, P21

[4] A phase II study of gemcitabine in gallbladder carcinoma [J].

Gallardo, JO ;

Rubio, B ;

Fodor, M ;

Orlandi, L ;

Yáñez, M ;

Gamargo, C ;

Ahumada, M .

ANNALS OF ONCOLOGY, 2001, 12 (10) :1403-1406

[5] Cancer statistics, 2001 [J].

Greenlee, RT ;

Hill-Harmon, MB ;

Murray, T ;

Thun, M .

CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36

[6] Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial [J].

Knox, JJ ;

Hedley, D ;

Oza, A ;

Feld, R ;

Sin, LL ;

Chen, E ;

Nematollahi, M ;

Pond, GR ;

Zhang, J ;

Moore, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2332-2338

[7]

Reyes-Vidal J, 2003, P AN M AM SOC CLIN, V22, P273

← 1 →